Article Text

Download PDFPDF
Citrobacter freundii sepsis in an immunosuppressed patient with pemphigus vulgaris
  1. Martina Ferranti1,
  2. Giulia Tadiotto Cicogna1,
  3. Andrea Sattin2 and
  4. Mauro Alaibac1
  1. 1 Unit of Dermatology, University of Padua, Padua, Italy
  2. 2 Unit of Infectious Disease, University of Padua, Padua, Italy
  1. Correspondence to Professor Mauro Alaibac, mauro.alaibac{at}


Pemphigus vulgaris is an autoimmune bullous disease that involves the skin and mucous membranes. Current therapies aim to decrease antibody production by means of the use of systemic corticosteroids, immunosuppressive agents and, recently, rituximab, an anti-CD20 monoclonal antibody. However, the chronic immune suppression could entail complications, like infections and secondary malignancies. We describe a case of a patient with pemphigus who developed a sepsis due to Citrobacter freundii infection.

  • dermatology
  • infections
View Full Text

Statistics from


  • Patient consent for publication Obtained.

  • Contributors MF, GTC, AS and MA made substantial contributions to the conception, acquisition, analysis and interpretation of data; and drafting the work and revising it critically for important intellectual content. All authors gave final approval of the version published.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.